Get started
Author

Nikica Mirošević Skvrce

Observed names: N. Mirosevic Skvrce, N. Mirošević Skvrce, Nikica Mirosevic Skvrce, Nikica Mirosević Skvrce, Nikica Miroševic Skvrce
ORCID: 0000-0002-3222-0345
Observed ORCID: 0000-0002-3222-0345
OpenAlex ID: A5088299230
Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study
2011 · Nikica Mirošević Skvrce, Viola Macolić Šarinić, et al. · Croatian Medical Journal · 61
PDF
Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults
2023 · Michael Denkinger, Wilma Knol, et al. · The Lancet Healthy Longevity · 44
PDF
ABCG2 Gene Polymorphisms as Risk Factors for Atorvastatin Adverse Reactions: A Case–Control Study
2015 · Nikica Mirošević Skvrce, Viola Macolić Šarinić, et al. · Pharmacogenomics · 42
CYP2C9 and ABCG2 Polymorphisms as Risk Factors for Developing Adverse Drug Reactions in Renal Transplant Patients Taking Fluvastatin: A Case–Control Study
2013 · Nikica Miroševic Skvrce, Nada Božina, et al. · Pharmacogenomics · 38
Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9 , CYP2C19 , CYP2D6 , CYP3A4 , and CYP3A5 in the Croatian population
2017 · Lana Ganoci, Tamara Božina, et al. · Drug Metabolism and Personalized Therapy · 33
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose
2023 · Monika Raethke, Florence van Hunsel, et al. · Drug Safety · 28
PDF
Use of pharmacogenomics in elderly patients treated for cardiovascular diseases
2020 · Nada Božina, Majda Vrkić Kirhmajer, et al. · Croatian Medical Journal · 24
PDF
Medicines for an aging population: The EMA perspective and policies
2024 · Francesca Cerreta, Ewa Balkowiec Iskra, et al. · Journal of the American Geriatrics Society · 9
Adverse drug reactions that arise from the use of medicinal products outside the terms of the marketing authorisation
2019 · Nikica Mirosevic Skvrce, Iva Galic, et al. · Research in Social and Administrative Pharmacy · 8
Root cause analysis of medication errors of the most frequently involved active substances in paediatric patients
2023 · Nikica Mirosevic Skvrce, Lana Omrcen, et al. · Research in Social and Administrative Pharmacy · 6
Implementation of Pharmacogenomics in Product Information
2020 · Nikica Mirošević Skvrce, Sonja Krivokapić, et al. · Pharmacogenomics · 5
Adverse drug reactions of psycopharmacs.
2010 · Nikica Mirosević Skvrce, Selma Arapović, et al. · PubMed · 2
PDF
The readiness of the spontaneous reporting system for COVID-19 vaccines safety monitoring in Croatia
2023 · Barbara Kovačić, Morana Pavičić, et al. · Acta Pharmaceutica · 1
PDF
Integrating Pharmacovigilance and Pharmacogenomics: Croatian Experience
2016 · N. Bozina, N. Mirosevic Skvrce, et al. · Clinical Therapeutics · 1
[Adverse drug reactions of hydroxymethylglutaryl-CoA reductase inhibitors reported to agency for medicinal products and medical devices].
2010 · Nikica Mirosević Skvrce, Nada Bozina, et al. · PubMed · 1
Farmakoterapija šećerne bolesti tipa 2
2019 · Josipa Cvek, Nikica Mirošević Skvrce, et al. · Repozitorij Farmaceutsko-biokemijskog fakulteta (Sveučilišta u Zagrebu)
Farmakogenomika – bitna karika personalizirane medicine
2018 · Nada Božina, Lana Ganoci, et al.
Sprječavanje pogrešne primjene i zlouporabe kodeina
2017 · Andrea Pogačić, Tessa Radovanović, et al. · Repozitorij Farmaceutsko-biokemijskog fakulteta (Sveučilišta u Zagrebu)
PDF
The Role of Pharmacogenetic Testing in the Evaluation of Drug-Induced Liver Injury
2016 · M. Stanić Benić, N. Mirošević Skvrce, et al. · Clinical Therapeutics
Integrating Pharmacogenomics with Pharmacovigilance
2015 · Nada Božina, Nikica Mirošević Skvrce, et al.
ABCG2 and CYP3A4 polymorphisms as a risk factors for developing adverse drug reactions in patients taking atorvastatin: a case-control study
2015 · Nikica Mirošević Skvrce, Lana Ganoci, et al.
Integrating Pharmacogenomics with Pharmacovigilance- Croatian Experience
2015 · Nada Božina, Nikica Mirošević Skvrce, et al. · Drug Safety
Drug transporter and metabolic enzyme gene variants and fluvastatin adverse drug reactions in renal transplant recipients
2013 · Nikica Mirošević Skvrce, Nada Božina, et al. · European Journal of Human Genetics
ABCG2 gene variant and fluvastatin adverse drug reactions in renal transplant recipients
2012 · Nikica Mirošević Skvrce, Nada Božina, et al. · Biochemia Medica
Nuspojave inhibitora 3-hidroksi-3-metil-glutaril koenzim A reduktaze prijavljene agenciji za lijekove i medicinske proizvode
2010 · Nikica Mirošević Skvrce, Nada Božina, et al. · University of Zagreb University Computing Centre (SRCE)
PDF
Works count: 25
Citation count: 303
H-index: 8
I10-index: 7
Year
Topic
Type